Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 518

1.

Rationale and design of a randomized, controlled, superiority trial on areca nut/betel quid cessation: The Betel Nut Intervention Trial (BENIT).

Paulino YC, Wilkens LR, Sotto PP, Franke AA, Kawamoto CT, Chennaux JSN, Mendez AJ, Tenorio LF, Badowski G, Pokhrel P, Herzog TA.

Contemp Clin Trials Commun. 2020 Feb 21;17:100544. doi: 10.1016/j.conctc.2020.100544. eCollection 2020 Mar.

2.

Molecular variations in uterine carcinosarcomas identify therapeutic opportunities.

Crane E, Naumann W, Tait D, Higgins R, Herzog T, Brown J.

Int J Gynecol Cancer. 2020 Feb 28. pii: ijgc-2019-000920. doi: 10.1136/ijgc-2019-000920. [Epub ahead of print]

PMID:
32114514
3.

A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients.

Pishvaian MJ, Blais EM, Bender RJ, Rao S, Boca SM, Chung V, Hendifar AE, Mikhail S, Sohal DPS, Pohlmann PR, Moore KN, He K, Monk BJ, Coleman RL, Herzog TJ, Halverson DD, DeArbeloa P, Petricoin EF 3rd, Madhavan S.

JAMIA Open. 2019 Oct 7;2(4):505-515. doi: 10.1093/jamiaopen/ooz045. eCollection 2019 Dec.

4.

Barriers to Quitting Areca Nut Consumption and Joining a Cessation Program as Perceived by Chewer and Nonchewer Populations in Guam.

Sotto PP, Mendez AJ, Herzog TA, Cruz C, Chennaux JSN, Legdesog C, Paulino YC.

Subst Use Misuse. 2020 Jan 24:1-7. doi: 10.1080/10826084.2020.1716012. [Epub ahead of print]

PMID:
31973623
5.

A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer.

Monk BJ, Herzog TJ, Wang G, Triantos S, Maul S, Knoblauch R, McGowan T, Shalaby WSW, Coleman RL.

Gynecol Oncol. 2020 Mar;156(3):535-544. doi: 10.1016/j.ygyno.2019.12.043. Epub 2020 Jan 8.

PMID:
31924332
6.

European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies.

Herzog TJ, Secord AA, Coleman RL, Naumann RW.

Gynecol Oncol. 2020 Feb;156(2):265-270. doi: 10.1016/j.ygyno.2019.11.010. Epub 2020 Jan 3.

PMID:
31911006
7.

Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer.

Jones NL, Xiu J, Rocconi RP, Herzog TJ, Winer IS.

Gynecol Oncol. 2020 Feb;156(2):393-399. doi: 10.1016/j.ygyno.2019.11.035. Epub 2019 Dec 24.

PMID:
31882243
8.

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.

Coleman RL, Spirtos NM, Enserro D, Herzog TJ, Sabbatini P, Armstrong DK, Kim JW, Park SY, Kim BG, Nam JH, Fujiwara K, Walker JL, Casey AC, Alvarez Secord A, Rubin S, Chan JK, DiSilvestro P, Davidson SA, Cohn DE, Tewari KS, Basen-Engquist K, Huang HQ, Brady MF, Mannel RS.

N Engl J Med. 2019 Nov 14;381(20):1929-1939. doi: 10.1056/NEJMoa1902626.

PMID:
31722153
9.

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.

Vergote I, du Bois A, Floquet A, Rau J, Kim JW, Del Campo JM, Friedlander M, Pignata S, Fujiwara K, Colombo N, Mirza MR, Monk BJ, Tsibulak I, Calvert PM, Herzog TJ, Hanker LC, Meunier J, Lee JY, Bologna A, Carrasco-Alfonso MJ, Harter P.

Gynecol Oncol. 2019 Nov;155(2):186-191. doi: 10.1016/j.ygyno.2019.08.024. Epub 2019 Sep 10.

10.

Does autologous fibrin sealant (vivostat©) reduce the incidence of postoperative pancreatic fistula after distal pancreatectomy? - a matched pairs analysis.

Luu AM, Braumann C, Uhl W, Janot-Matuschek M, Herzog T.

Acta Chir Belg. 2019 Aug 30:1-7. doi: 10.1080/00015458.2019.1658354. [Epub ahead of print]

PMID:
31433745
11.

OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.

Webber K, Carolus E, Mileshkin L, Sommeijer D, McAlpine J, Bladgen S, Coleman RL, Herzog TJ, Sehouli J, Nasser S, Inci G, Friedlander M.

Gynecol Oncol. 2019 Oct;155(1):126-134. doi: 10.1016/j.ygyno.2019.08.009. Epub 2019 Aug 13.

PMID:
31416612
12.

An unusual case of uterine PEComa presenting with disseminated intravascular coagulation.

Rothenberger R, Jackson A, Kendler A, Herzog T, Billingsley C.

Gynecol Oncol Rep. 2019 Jun 25;29:76-78. doi: 10.1016/j.gore.2019.06.007. eCollection 2019 Aug.

13.

Joint ENGOT and GOG Foundation requirements for trials with industry partners.

Vergote I, Coleman RL, Pignata S, Bookman MA, Marth C, Herzog TJ, Gonzalez-Martin A, Copeland LJ; European Network of Gynaecological Oncological Trial Groups (ENGOT); GOG Foundation Inc.

Gynecol Oncol. 2019 Aug;154(2):255-258. doi: 10.1016/j.ygyno.2019.04.677. No abstract available.

PMID:
31331494
14.

Joint ENGOT and GOG Foundation requirements for trials with industry partners.

Vergote I, Coleman RL, Pignata S, Bookman MA, Marth C, Herzog TJ, Gonzalez Martin A, Copeland LJ; European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc.

Int J Gynecol Cancer. 2019 Sep;29(7):1094-1097. doi: 10.1136/ijgc-2019-000441. Epub 2019 Jul 18. No abstract available.

PMID:
31320391
15.

Comparison of 3 Methods to Assess Occupational Sevoflurane Exposure in Abdominal Surgeons: A Single-Center Observational Pilot Study.

Herzog-Niescery J, Seipp HM, Bellgardt M, Herzog T, Belyaev O, Uhl W, Gude P, Weber TP, Vogelsang H.

Anesth Analg. 2019 Jul 5. doi: 10.1213/ANE.0000000000004301. [Epub ahead of print]

PMID:
31295179
16.

Adolescent betel nut use in Guam: beliefs, attitudes and social norms.

Dalisay F, Buente W, Benitez C, Herzog TA, Pokhrel P.

Addict Res Theory. 2019;27(5):394-404. doi: 10.1080/16066359.2018.1538410. Epub 2019 Jan 11.

17.

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.

Tewari KS, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ.

J Clin Oncol. 2019 Sep 10;37(26):2317-2328. doi: 10.1200/JCO.19.01009. Epub 2019 Jun 19.

PMID:
31216226
18.

Advancing Drug Development in Gynecologic Malignancies.

Beaver JA, Coleman RL, Arend RC, Armstrong DK, Bala S, Mills GB, Sood AK, Herzog TJ.

Clin Cancer Res. 2019 Aug 15;25(16):4874-4880. doi: 10.1158/1078-0432.CCR-19-0619. Epub 2019 May 24.

PMID:
31126961
19.

Adolescent Tobacco and Betel Nut Use in the US-Affiliated Pacific Islands: Evidence From Guam.

Pokhrel P, Dalisay F, Pagano I, Buente W, Guerrero E, Herzog TA.

Am J Health Promot. 2019 Sep;33(7):1058-1062. doi: 10.1177/0890117119847868. Epub 2019 May 22.

20.

Loss of BRUCE reduces cellular energy level and induces autophagy by driving activation of the AMPK-ULK1 autophagic initiating axis.

Che L, Yang X, Ge C, El-Amouri SS, Wang QE, Pan D, Herzog TJ, Du C.

PLoS One. 2019 May 15;14(5):e0216553. doi: 10.1371/journal.pone.0216553. eCollection 2019.

21.

Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing Practice.

Randall LM, Birrer MJ, Herzog TJ.

Oncologist. 2019 May;24(5):576-579. doi: 10.1634/theoncologist.2019-0020. Epub 2019 Mar 20.

22.

Treatment of patients with recurrent epithelial ovarian cancer for whom platinum is still an option.

Buechel M, Herzog TJ, Westin SN, Coleman RL, Monk BJ, Moore KN.

Ann Oncol. 2019 May 1;30(5):721-732. doi: 10.1093/annonc/mdz104.

23.

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.

Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, Abu-Zidan FM, Ansaloni L, Augustin G, Bala M, Ben-Ishay O, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cortese F, Cui Y, Czepiel J, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckmann C, Eiland EH, Forrester JD, Fraga GP, Frossard JL, Fry DE, Galeiras R, Ghnnam W, Gomes CA, Griffiths EA, Guirao X, Ahmed MH, Herzog T, Kim JI, Iqbal T, Isik A, Itani KMF, Labricciosa FM, Lee YY, Juang P, Karamarkovic A, Kim PK, Kluger Y, Leppaniemi A, Lohsiriwat V, Machain GM, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Ordoñez CA, Pagani L, Petrosillo N, Portela F, Rasa K, Rems M, Sakakushev BE, Segovia-Lohse H, Sganga G, Shelat VG, Spigaglia P, Tattevin P, Tranà C, Urbánek L, Ulrych J, Viale P, Baiocchi GL, Catena F.

World J Emerg Surg. 2019 Feb 28;14:8. doi: 10.1186/s13017-019-0228-3. eCollection 2019. Review.

24.

Limits of Life and the Habitability of Mars: The ESA Space Experiment BIOMEX on the ISS.

de Vera JP, Alawi M, Backhaus T, Baqué M, Billi D, Böttger U, Berger T, Bohmeier M, Cockell C, Demets R, de la Torre Noetzel R, Edwards H, Elsaesser A, Fagliarone C, Fiedler A, Foing B, Foucher F, Fritz J, Hanke F, Herzog T, Horneck G, Hübers HW, Huwe B, Joshi J, Kozyrovska N, Kruchten M, Lasch P, Lee N, Leuko S, Leya T, Lorek A, Martínez-Frías J, Meessen J, Moritz S, Moeller R, Olsson-Francis K, Onofri S, Ott S, Pacelli C, Podolich O, Rabbow E, Reitz G, Rettberg P, Reva O, Rothschild L, Sancho LG, Schulze-Makuch D, Selbmann L, Serrano P, Szewzyk U, Verseux C, Wadsworth J, Wagner D, Westall F, Wolter D, Zucconi L.

Astrobiology. 2019 Feb;19(2):145-157. doi: 10.1089/ast.2018.1897.

25.

Content analysis of internet marketing strategies used to promote flavored electronic cigarettes.

Soule EK, Sakuma KK, Palafox S, Pokhrel P, Herzog TA, Thompson N, Fagan P.

Addict Behav. 2019 Apr;91:128-135. doi: 10.1016/j.addbeh.2018.11.012. Epub 2018 Nov 14.

PMID:
30606627
26.

Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23].

Olawaiye AB, Java JJ, Krivak TC, Friedlander M, Mutch DG, Glaser G, Geller M, O'Malley DM, Wenham RM, Lee RB, Bodurka DC, Herzog TJ, Bookman MA.

Gynecol Oncol. 2019 Jan;152(1):220. doi: 10.1016/j.ygyno.2018.10.022. Epub 2018 Oct 23. No abstract available.

27.

Efficiencies and noise levels of portable surgical smoke evacuation systems.

Seipp HM, Steffens T, Weigold J, Lahmer A, Maier-Hasselmann A, Herzog T, Herzog-Niescery J.

J Occup Environ Hyg. 2018 Nov;15(11):773-781. doi: 10.1080/15459624.2018.1513134.

PMID:
30156970
28.

Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.

Arend RC, Toboni MD, Montgomery AM, Burger RA, Olawaiye AB, Monk BJ, Herzog TJ.

Oncologist. 2018 Dec;23(12):1533-1545. doi: 10.1634/theoncologist.2018-0095. Epub 2018 Aug 23.

29.

Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.

Olawaiye AB, Java JJ, Krivak TC, Friedlander M, Mutch DG, Glaser G, Geller M, O'Malley DM, Wenham RM, Lee RB, Bodurka DC, Herzog TJ, Bookman MA.

Gynecol Oncol. 2018 Oct;151(1):18-23. doi: 10.1016/j.ygyno.2018.07.021. Epub 2018 Aug 19. Erratum in: Gynecol Oncol. 2018 Oct 22;:.

30.

FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer.

Luu AM, Herzog T, Hoehn P, Reinacher-Schick A, Munding J, Uhl W, Braumann C.

J Gastrointest Oncol. 2018 Apr;9(2):E9-E12. doi: 10.21037/jgo.2018.01.07.

31.

Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Herzog T, Levitan J, Moderau N, Schwartzberg L, Tabassum N, Wen J, Krell J, Stebbing J.

Oncotarget. 2018 Mar 13;9(19):15166. doi: 10.18632/oncotarget.24691. eCollection 2018 Mar 13.

32.

Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Fotopoulou C, Frilling A, Herzog T, Moderau N, Tabassum N, Krell J, Stebbing J.

Oncotarget. 2018 Mar 13;9(19):15164. doi: 10.18632/oncotarget.24689. eCollection 2018 Mar 13.

33.

Effect of indoor wheelchair curling training on trunk control of person with chronic spinal cord injury: a randomised controlled trial.

Herzog T, Swanenburg J, Hupp M, Mittaz Hager AG.

Spinal Cord Ser Cases. 2018 Mar 21;4:26. doi: 10.1038/s41394-018-0057-8. eCollection 2018.

34.

Diagnostic double strike in the emergency room - two cases of complete pancreatic ruptures due to bicycle handlebar injuries on two consecutive days.

Luu AM, Meurer K, Herzog T, Uhl W, Braumann C.

J Med Case Rep. 2018 Mar 26;12(1):85. doi: 10.1186/s13256-018-1594-2.

35.

Comparison of Measures of E-cigarette Advertising Exposure and Receptivity.

Pokhrel P, Fagan P, Herzog TA, Schmid S, Kawamoto CT, Unger JB.

Tob Regul Sci. 2017 Oct;3(4):424-434. doi: 10.18001/TRS.3.4.4. Epub 2017 Oct 1.

36.

Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Belluz LDB, Herzog T, Levitan J, Moderau N, Schwartzberg L, Tabassum N, Wen J, Krell J, Stebbing J.

Oncotarget. 2018 Jan 16;9(10):9456-9467. doi: 10.18632/oncotarget.24258. eCollection 2018 Feb 6. Erratum in: Oncotarget. 2018 Mar 13;9(19):15166.

37.

Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Fotopoulou C, Frilling A, Herzog T, Moderau N, Tabassum N, Krell J, Stebbing J.

Oncotarget. 2017 Dec 27;9(5):6007-6014. doi: 10.18632/oncotarget.23675. eCollection 2018 Jan 19. Erratum in: Oncotarget. 2018 Mar 13;9(19):15164.

38.

A modified single-loop reconstruction after pancreaticoduodenectomy reduces severity of postoperative pancreatic fistula in high-risk patients.

Aghalarov I, Herzog T, Uhl W, Belyaev O.

HPB (Oxford). 2018 Jul;20(7):676-683. doi: 10.1016/j.hpb.2018.01.011. Epub 2018 Feb 16.

39.

E-cigarette Advertising Exposure, Explicit and Implicit Harm Perceptions, and E-cigarette Use Susceptibility Among Nonsmoking Young Adults.

Pokhrel P, Herzog TA, Fagan P, Unger JB, Stacy AW.

Nicotine Tob Res. 2019 Jan 1;21(1):127-131. doi: 10.1093/ntr/nty030.

40.

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.

Friedlander M, Rau J, Lee CK, Meier W, Lesoin A, Kim JW, Poveda A, Buck M, Scambia G, Shimada M, Hilpert F, King MT, Debruyne P, Bologna A, Malander S, Monk BJ, Petru E, Calvert P, Herzog TJ, Barrett C, du Bois A.

Ann Oncol. 2018 Mar 1;29(3):737-743. doi: 10.1093/annonc/mdx796.

41.

Young adult e-cigarette use outcome expectancies: Validity of a revised scale and a short scale.

Pokhrel P, Lam TH, Pagano I, Kawamoto CT, Herzog TA.

Addict Behav. 2018 Mar;78:193-199. doi: 10.1016/j.addbeh.2017.11.019. Epub 2017 Nov 11.

42.

Sugar and Aldehyde Content in Flavored Electronic Cigarette Liquids.

Fagan P, Pokhrel P, Herzog TA, Moolchan ET, Cassel KD, Franke AA, Li X, Pagano I, Trinidad DR, Sakuma KK, Sterling K, Jorgensen D, Lynch T, Kawamoto C, Guy MC, Lagua I, Hanes S, Alexander LA, Clanton MS, Graham-Tutt C, Eissenberg T; Addictive Carcinogens Workgroup.

Nicotine Tob Res. 2018 Jul 9;20(8):985-992. doi: 10.1093/ntr/ntx234.

43.

Social media e-cigarette exposure and e-cigarette expectancies and use among young adults.

Pokhrel P, Fagan P, Herzog TA, Laestadius L, Buente W, Kawamoto CT, Lee HR, Unger JB.

Addict Behav. 2018 Mar;78:51-58. doi: 10.1016/j.addbeh.2017.10.017. Epub 2017 Nov 8.

44.

Physical therapy is targeted and adjusted over time for the rehabilitation of locomotor function in acute spinal cord injury interventions in physical and sports therapy.

Franz M, Richner L, Wirz M, von Reumont A, Bergner U, Herzog T, Popp W, Bach K, Weidner N, Curt A.

Spinal Cord. 2018 Feb;56(2):158-167. doi: 10.1038/s41393-017-0007-5. Epub 2017 Oct 23.

PMID:
29057989
45.

Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?

Herzog TJ, Monk BJ.

Gynecol Oncol Res Pract. 2017 Sep 7;4:13. doi: 10.1186/s40661-017-0050-0. eCollection 2017. Review.

46.

FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper.

Herzog TJ, Ison G, Alvarez RD, Balasubramaniam S, Armstrong DK, Beaver JA, Ellis A, Tang S, Ford P, McKee A, Gershenson DM, Kim G, Monk BJ, Pazdur R, Coleman RL.

Gynecol Oncol. 2017 Oct;147(1):3-10. doi: 10.1016/j.ygyno.2017.08.012. Epub 2017 Aug 24. Review. No abstract available.

PMID:
28844539
47.

Surgery for Refractory Coccygodynia: Operative Versus Nonoperative Treatment.

Kleimeyer JP, Wood KB, Lønne G, Herzog T, Ju K, Beyer L, Park C.

Spine (Phila Pa 1976). 2017 Aug 15;42(16):1214-1219. doi: 10.1097/BRS.0000000000002053.

PMID:
28800569
48.

Erratum to: The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.

Sartelli M, Chichom-Mefire A, Labricciosa FM, Hardcastle T, Abu-Zidan FM, Adesunkanmi AK, Ansaloni L, Bala M, Balogh ZJ, Beltrán MA, Ben-Ishay O, Biffl WL, Birindelli A, Cainzos MA, Catalini G, Ceresoli M, Che Jusoh A, Chiara O, Coccolini F, Coimbra R, Cortese F, Demetrashvili Z, Di Saverio S, Diaz JJ, Egiev VN, Ferrada P, Fraga GP, Ghnnam WM, Lee JG, Gomes CA, Hecker A, Herzog T, Kim JI, Inaba K, Isik A, Karamarkovic A, Kashuk J, Khokha V, Kirkpatrick AW, Kluger Y, Koike K, Kong VY, Leppaniemi A, Machain GM, Maier RV, Marwah S, McFarlane ME, Montori G, Moore EE, Negoi I, Olaoye I, Omari AH, Ordonez CA, Pereira BM, Pereira Júnior GA, Pupelis G, Reis T, Sakakushev B, Sato N, Segovia Lohse HA, Shelat VG, Søreide K, Uhl W, Ulrych J, Van Goor H, Velmahos GC, Yuan KC, Wani I, Weber DG, Zachariah SK, Catena F.

World J Emerg Surg. 2017 Aug 2;12:36. doi: 10.1186/s13017-017-0148-z. eCollection 2017.

49.

Erratum to: Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).

Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P.

World J Emerg Surg. 2017 Aug 2;12:35. doi: 10.1186/s13017-017-0147-0. eCollection 2017.

50.

The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.

Sartelli M, Chichom-Mefire A, Labricciosa FM, Hardcastle T, Abu-Zidan FM, Adesunkanmi AK, Ansaloni L, Bala M, Balogh ZJ, Beltrán MA, Ben-Ishay O, Biffl WL, Birindelli A, Cainzos MA, Catalini G, Ceresoli M, Che Jusoh A, Chiara O, Coccolini F, Coimbra R, Cortese F, Demetrashvili Z, Di Saverio S, Diaz JJ, Egiev VN, Ferrada P, Fraga GP, Ghnnam WM, Lee JG, Gomes CA, Hecker A, Herzog T, Kim JI, Inaba K, Isik A, Karamarkovic A, Kashuk J, Khokha V, Kirkpatrick AW, Kluger Y, Koike K, Kong VY, Leppaniemi A, Machain GM, Maier RV, Marwah S, McFarlane ME, Montori G, Moore EE, Negoi I, Olaoye I, Omari AH, Ordonez CA, Pereira BM, Pereira Júnior GA, Pupelis G, Reis T, Sakakhushev B, Sato N, Segovia Lohse HA, Shelat VG, Søreide K, Uhl W, Ulrych J, Van Goor H, Velmahos GC, Yuan KC, Wani I, Weber DG, Zachariah SK, Catena F.

World J Emerg Surg. 2017 Jul 10;12:29. doi: 10.1186/s13017-017-0141-6. eCollection 2017. Review. Erratum in: World J Emerg Surg. 2017 Aug 2;12 :36.

Supplemental Content

Loading ...
Support Center